Precigen, Inc
Clinical trials sponsored by Precigen, Inc, explained in plain language.
-
New study tests second round of gene therapy for rare throat condition
Disease control Recruiting nowThis study is testing a second course of an experimental gene therapy called zopapogene imadenovec for adults with recurrent respiratory papillomatosis (RRP), a rare condition causing wart-like growths in the throat. Researchers want to see if a repeat treatment is safe and effec…
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Apr 04, 2026 04:51 UTC
-
New hope for advanced cervical cancer: trial tests drug combo after standard treatment fails
Disease control Recruiting nowThis study is for people with advanced cervical cancer that has returned or spread and is no longer responding to the immunotherapy drug pembrolizumab. It will test if adding a new investigational drug called PRGN-2009 to pembrolizumab is more effective and safe than continuing p…
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC